user

PLASMA LEVELS OF HEPARANASE AS A MARKER OF TUMOR PROGRESSION AND AGGRESSIVENESS IN PATIENTS WITH COLORECTAL AND BREAST CANCER

被引：0
|
作者：
Kuten, J. [1 ]
Haim, N. [2 ]
Epelbaum, R. [1 ]
Fried, G. [1 ]
Ben Itzhak, O. [3 ]
Danus, S. [1 ]
Shaft, I. [3 ]
Vlodavsky, I. [3 ]
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Rambam Hlth Care Campus, Oncol, Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [41] Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment
    Shafat, Itay
    Ben Baraky, Ayelet
    Postovskyy, Sergey
    Elhasidy, Ronit
    Ilan, Neta
    Vlodavsky, Israel
    Ben Arush, Miriam Weyl
    NEOPLASIA, 2007, 9 (11): : 909 - 916
  • [42] PLASMA AND TUMOR PROLACTIN IN COLORECTAL-CANCER PATIENTS
    ILAN, Y
    SIBIRSTY, O
    LIVNI, N
    GOFRIT, O
    BARACK, V
    ROSENMAN, E
    DURST, A
    GOLDIN, E
    GASTROENTEROLOGY, 1994, 106 (04) : A396 - A396
  • [43] PLASMA AND TUMOR PROLACTIN IN COLORECTAL-CANCER PATIENTS
    ILAN, Y
    SIBIRSKY, O
    LIVNI, N
    GOFRIT, O
    BARACK, V
    GOLDIN, E
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (09) : 2010 - 2015
  • [44] PLASMA PROLACTIN AS A TUMOR-MARKER IN ADVANCED BREAST-CANCER
    BHATAVDEKAR, JM
    SHAH, NG
    GIRI, DD
    KARELIA, NH
    TRIVEDI, SN
    VORA, HH
    PATEL, DD
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 177 - 177
  • [45] Comparison of 18 F FDG PET CT and tumor marker findings in advanced breast cancer patients with progression
    Bayar, E. E.
    Gur, E. O.
    Bural, G. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S659 - S660
  • [46] Value of endoscopic ultrasonography for assessment of patients presenting elevated tumor marker levels after surgery for colorectal cancer
    Giovannini, M
    Seitz, JF
    Perrier, H
    Hardvissen, J
    Houvenaeghel, G
    Monges, G
    Delpero, JR
    GASTROENTEROLOGY, 1996, 110 (04) : A519 - A519
  • [47] Plasma levels of matrix metalloproteinases in patients with breast cancer as a potential marker of cardiotoxicity associated with doxorubicin therapy
    Karputs, I. A.
    Snezhitskiy, V. A.
    Kurbat, M. N.
    Kaliadka, M. H.
    Perapechai, M. A.
    Kolyadko, N. N.
    Babenka, A. S.
    CLINICA CHIMICA ACTA, 2024, 558 : 81 - 81
  • [48] The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location
    Papagiorgis, Petros C.
    Zizi, Adamantia E.
    Tseleni, Sophia
    Oikonomakis, Ioannis N.
    Nikiteas, Nikolaos I.
    ONCOLOGY LETTERS, 2012, 3 (05) : 1129 - 1135
  • [49] Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer
    Tsai, Wen-Sy
    Changchien, Chung Rong
    Yeh, Chien-Yuh
    Chen, Jinn-Shiun
    Tang, Reiping
    Chiang, Jy-Ming
    Hsieh, Pao-Shiu
    Fan, Chung Wei
    Wang, Jeng Yi
    DISEASES OF THE COLON & RECTUM, 2006, 49 (06) : 883 - 894
  • [50] GENE EXPRESSION IN BREAST CANCER DEPENDS ON TUMOR AGGRESSIVENESS
    Ferrin, V.
    Bocos, C.
    Schneider, J.
    Martin, E.
    Alvarez-Millan, J. J.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3421 - 3421
12345